Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, Brenner H, Bueno-de-Mesquita B, Buring J, Campa D, Capurso G, Cavestro GM, Chaffee KG, Chung CC, Cleary S, Cotterchio M, Dijk F, Duell EJ, Foretova L, Fuchs C, Funel N, Gallinger S, M Gaziano JM, Gazouli M, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Hackert T, Haiman C, Hartge P, Hasan M, Hegyi P, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Jacobs EJ, Jamroziak K, Janout V, Kaaks R, Khaw KT, Klein EA, Kogevinas M, Kooperberg C, Kulke MH, Kupcinskas J, Kurtz RJ, Laheru D, Landi S, Lawlor RT, Lee IM, LeMarchand L, Lu L, Malats N, Mambrini A, Mannisto S, Milne RL, Mohelníková-Duchoňová B, Neale RE, Neoptolemos JP, Oberg AL, Olson SH, Orlow I, Pasquali C, Patel AV, Peters U, Pezzilli R, Porta M, Real FX, Rothman N, Scelo G, Sesso HD, Severi G, Shu XO, Silverman D, Smith JP, Soucek P, Sund M, Talar-Wojnarowska R, Tavano F, Thornquist MD, Tobias GS, Van Den Eeden SK, Vashist Y, Visvanathan K, Vodicka P, Wactawski-Wende J, Wang Z, Wentzensen N, White E, Yu H, Yu K, Zeleniuch-Jacquotte A, Zheng W, Kraft P, Li D, Chanock S, Obazee O, Petersen GM, Amundadottir LT.

Nat Commun. 2018 Feb 8;9(1):556. doi: 10.1038/s41467-018-02942-5.

2.

"We're Just Not Prepared for Eating Over Our Whole Life": A Mixed Methods Approach to Understanding Dietary Behaviors Among Longer Term Cancer Survivors.

Klassen AC, Smith KC, Shuster M, Coa KI, Caulfield LE, Helzlsouer KJ, Peairs KS, Shockney LD, Stoney D, Hannum S.

Integr Cancer Ther. 2018 Jun;17(2):350-362. doi: 10.1177/1534735417731515. Epub 2017 Oct 3.

3.

Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.

Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, Lundin E, Onland-Moret NC, Rinaldi S, Schock H, Shu XO, Sluss PM, Staats PN, Sacerdote C, Travis RC, Tjønneland A, Trichopoulou A, Tworoger SS, Visvanathan K, Weiderpass E, Zeleniuch-Jacquotte A, Dorgan JF.

Int J Cancer. 2018 Jan 15;142(2):262-270. doi: 10.1002/ijc.31058. Epub 2017 Oct 4.

PMID:
28921520
4.

Anti-Mullerian hormone and endometrial cancer: a multi-cohort study.

Fortner RT, Schock H, Jung S, Allen NE, Arslan AA, Brinton LA, Egleston BL, Falk RT, Gunter MJ, Helzlsouer KJ, Idahl A, Johnson TS, Kaaks R, Krogh V, Lundin E, Merritt MA, Navarro C, Onland-Moret NC, Palli D, Shu XO, Sluss PM, Staats PN, Trichopoulou A, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF.

Br J Cancer. 2017 Oct 24;117(9):1412-1418. doi: 10.1038/bjc.2017.299. Epub 2017 Sep 5.

PMID:
28873086
5.

Updating the landscape of direct-to-consumer pharmacogenomic testing.

Filipski KK, Murphy JD, Helzlsouer KJ.

Pharmgenomics Pers Med. 2017 Aug 22;10:229-232. doi: 10.2147/PGPM.S140461. eCollection 2017. Review.

6.

Strengthening Global Partnership in Breast Cancer Research.

Trimble EL, Helzlsouer KJ.

J Glob Oncol. 2016 Jul 27;2(5):253-254. doi: 10.1200/JGO.2016.005264. eCollection 2016 Oct. No abstract available.

7.

Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.

Jung S, Allen N, Arslan AA, Baglietto L, Brinton LA, Egleston BL, Falk R, Fortner RT, Helzlsouer KJ, Idahl A, Kaaks R, Lundin E, Merritt M, Onland-Moret C, Rinaldi S, Sánchez MJ, Sieri S, Schock H, Shu XO, Sluss PM, Staats PN, Travis RC, Tjønneland A, Trichopoulou A, Tworoger S, Visvanathan K, Krogh V, Weiderpass E, Zeleniuch-Jacquotte A, Zheng W, Dorgan JF.

Fertil Steril. 2017 Apr;107(4):1012-1022.e2. doi: 10.1016/j.fertnstert.2017.02.105.

8.

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.

Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Kamineni A, Kolonel LN, Kulke MH, Malats N, Olson SH, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Brais L, Bueno-de-Mesquita HB, Basso D, Berndt SI, Boutron-Ruault MC, Bijlsma MF, Brenner H, Burdette L, Campa D, Caporaso NE, Capurso G, Cavestro GM, Cotterchio M, Costello E, Elena J, Boggi U, Gaziano JM, Gazouli M, Giovannucci EL, Goggins M, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Hu N, Hunter DJ, Iskierka-Jazdzewska E, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Neale RE, Oberg AL, Panico S, Patel AV, Peeters PH, Peters U, Pezzilli R, Porta M, Purdue M, Quiros JR, Riboli E, Rothman N, Scarpa A, Scelo G, Shu XO, Silverman DT, Soucek P, Strobel O, Sund M, Małecka-Panas E, Taylor PR, Tavano F, Travis RC, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vashist Y, Vodicka P, Wactawski-Wende J, Wentzensen N, Yu H, Yu K, Zeleniuch-Jacquotte A, Kooperberg C, Risch HA, Jacobs EJ, Li D, Fuchs C, Hoover R, Hartge P, Chanock SJ, Petersen GM, Stolzenberg-Solomon RS, Wolpin BM, Kraft P, Klein AP, Canzian F, Amundadottir LT.

Oncotarget. 2016 Oct 11;7(41):66328-66343. doi: 10.18632/oncotarget.11041.

9.

Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.

Allen NE, Travis RC, Appleby PN, Albanes D, Barnett MJ, Black A, Bueno-de-Mesquita HB, Deschasaux M, Galan P, Goodman GE, Goodman PJ, Gunter MJ, Heliövaara M, Helzlsouer KJ, Henderson BE, Hercberg S, Knekt P, Kolonel LN, Lasheras C, Linseisen J, Metter EJ, Neuhouser ML, Olsen A, Pala V, Platz EA, Rissanen H, Reid ME, Schenk JM, Stampfer MJ, Stattin P, Tangen CM, Touvier M, Trichopoulou A, van den Brandt PA, Key TJ; Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group.

J Natl Cancer Inst. 2016 Jul 6;108(11). doi: 10.1093/jnci/djw153. Print 2016 Nov.

10.

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk.

Travis RC, Appleby PN, Martin RM, Holly JMP, Albanes D, Black A, Bueno-de-Mesquita HBA, Chan JM, Chen C, Chirlaque MD, Cook MB, Deschasaux M, Donovan JL, Ferrucci L, Galan P, Giles GG, Giovannucci EL, Gunter MJ, Habel LA, Hamdy FC, Helzlsouer KJ, Hercberg S, Hoover RN, Janssen JAMJL, Kaaks R, Kubo T, Le Marchand L, Metter EJ, Mikami K, Morris JK, Neal DE, Neuhouser ML, Ozasa K, Palli D, Platz EA, Pollak M, Price AJ, Roobol MJ, Schaefer C, Schenk JM, Severi G, Stampfer MJ, Stattin P, Tamakoshi A, Tangen CM, Touvier M, Wald NJ, Weiss NS, Ziegler RG, Key TJ, Allen NE.

Cancer Res. 2016 Apr 15;76(8):2288-2300. doi: 10.1158/0008-5472.CAN-15-1551. Epub 2016 Feb 26.

11.

Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.

Key TJ, Appleby PN, Travis RC, Albanes D, Alberg AJ, Barricarte A, Black A, Boeing H, Bueno-de-Mesquita HB, Chan JM, Chen C, Cook MB, Donovan JL, Galan P, Gilbert R, Giles GG, Giovannucci E, Goodman GE, Goodman PJ, Gunter MJ, Hamdy FC, Heliövaara M, Helzlsouer KJ, Henderson BE, Hercberg S, Hoffman-Bolton J, Hoover RN, Johansson M, Khaw KT, King IB, Knekt P, Kolonel LN, Le Marchand L, Männistö S, Martin RM, Meyer HE, Mondul AM, Moy KA, Neal DE, Neuhouser ML, Palli D, Platz EA, Pouchieu C, Rissanen H, Schenk JM, Severi G, Stampfer MJ, Tjønneland A, Touvier M, Trichopoulou A, Weinstein SJ, Ziegler RG, Zhou CK, Allen NE; Endogenous Hormones Nutritional Biomarkers Prostate Cancer Collaborative Group.

Am J Clin Nutr. 2015 Nov;102(5):1142-57. doi: 10.3945/ajcn.115.114306. Epub 2015 Oct 7.

12.

Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies.

Genkinger JM, Kitahara CM, Bernstein L, Berrington de Gonzalez A, Brotzman M, Elena JW, Giles GG, Hartge P, Singh PN, Stolzenberg-Solomon RZ, Weiderpass E, Adami HO, Anderson KE, Beane-Freeman LE, Buring JE, Fraser GE, Fuchs CS, Gapstur SM, Gaziano JM, Helzlsouer KJ, Lacey JV Jr, Linet MS, Liu JJ, Park Y, Peters U, Purdue MP, Robien K, Schairer C, Sesso HD, Visvanathan K, White E, Wolk A, Wolpin BM, Zeleniuch-Jacquotte A, Jacobs EJ.

Ann Oncol. 2015 Nov;26(11):2257-66. doi: 10.1093/annonc/mdv355. Epub 2015 Sep 7. Review.

13.

Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies.

Kakourou A, Koutsioumpa C, Lopez DS, Hoffman-Bolton J, Bradwin G, Rifai N, Helzlsouer KJ, Platz EA, Tsilidis KK.

Cancer Causes Control. 2015 Oct;26(10):1449-60. doi: 10.1007/s10552-015-0641-1. Epub 2015 Jul 29.

14.

Change in Pain and Quality of Life Among Women Enrolled in a Trial Examining the Use of Narrow Band Imaging During Laparoscopic Surgery for Suspected Endometriosis.

Gallicchio L, Helzlsouer KJ, Audlin KM, Miller C, MacDonald R, Johnston M, Barrueto FF.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1208-14. doi: 10.1016/j.jmig.2015.06.017. Epub 2015 Jun 30.

PMID:
26140829
15.

Sensitivity of Narrow Band Imaging Compared With White Light Imaging for the Detection of Endometriosis.

Barrueto FF, Audlin KM, Gallicchio L, Miller C, MacDonald R, Alonsozana E, Johnston M, Helzlsouer KJ.

J Minim Invasive Gynecol. 2015 Jul-Aug;22(5):846-52. doi: 10.1016/j.jmig.2015.04.005. Epub 2015 Apr 13.

PMID:
25881884
16.

Racial differences in depressive symptoms and self-rated health among breast cancer survivors on aromatase inhibitor therapy.

Calhoun C, Helzlsouer KJ, Gallicchio L.

J Psychosoc Oncol. 2015;33(3):263-77. doi: 10.1080/07347332.2015.1019661.

PMID:
25751493
17.

Clinical care providers' perspectives on body size and weight management among long-term cancer survivors.

Baker AM, Smith KC, Coa KI, Helzlsouer KJ, Caulfield LE, Peairs KS, Shockney LD, Klassen AC.

Integr Cancer Ther. 2015 May;14(3):240-8. doi: 10.1177/1534735415572882. Epub 2015 Feb 25.

18.

Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies.

Key TJ, Appleby PN, Reeves GK, Travis RC, Brinton LA, Helzlsouer KJ, Dorgan JF, Gapstur SM, Gaudet MM, Kaaks R, Riboli E, Rinaldi S, Manjer J, Hallmans G, Giles GG, Le Marchand L, Kolonel LN, Henderson BE, Tworoger SS, Hankinson SE, Zeleniuch-Jacquotte A, Koenig K, Krogh V, Sieri S, Muti P, Ziegler RG, Schairer C, Fuhrman BJ, Barrett-Connor E, Laughlin GA, Grant EJ, Cologne J, Ohishi W, Hida A, Cauley JA, Fourkala EO, Menon U, Rohan TE, Strickler HD, Gunter MJ; Endogenous Hormones and Breast Cancer Collaborative Group.

Steroids. 2015 Jul;99(Pt A):49-55. doi: 10.1016/j.steroids.2014.09.001. Epub 2014 Oct 7.

19.

Association of variants in genes related to the immune response and obesity with BPH in CLUE II.

Lopez DS, Peskoe SB, Tsilidis KK, Hoffman-Bolton J, Helzlsouer KJ, Isaacs WB, Smith MW, Platz EA.

Prostate Cancer Prostatic Dis. 2014 Dec;17(4):353-8. doi: 10.1038/pcan.2014.36. Epub 2014 Sep 16.

20.

Prospective study of seroreactivity to JC virus T-antigen and risk of colorectal cancers and adenomas.

Hampras SS, Viscidi RP, Helzlsouer KJ, Lee JH, Fulp WJ, Giuliano AR, Platz EA, Rollison DE.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2591-6. doi: 10.1158/1055-9965.EPI-14-0370. Epub 2014 Aug 15.

21.

Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors.

Olufade T, Gallicchio L, MacDonald R, Helzlsouer KJ.

Support Care Cancer. 2015 Feb;23(2):447-55. doi: 10.1007/s00520-014-2364-3. Epub 2014 Aug 17.

PMID:
25128067
22.

Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer.

Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Jacobs EJ, Kamineni A, Klein AP, Kolonel LN, Kulke MH, Li D, Malats N, Olson SH, Risch HA, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Austin MA, Barfield R, Basso D, Berndt SI, Boutron-Ruault MC, Brotzman M, Büchler MW, Bueno-de-Mesquita HB, Bugert P, Burdette L, Campa D, Caporaso NE, Capurso G, Chung C, Cotterchio M, Costello E, Elena J, Funel N, Gaziano JM, Giese NA, Giovannucci EL, Goggins M, Gorman MJ, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Henderson BE, Holly EA, Hu N, Hunter DJ, Innocenti F, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, LaCroix A, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Nakamura Y, Oberg AL, Owzar K, Patel AV, Peeters PH, Peters U, Pezzilli R, Piepoli A, Porta M, Real FX, Riboli E, Rothman N, Scarpa A, Shu XO, Silverman DT, Soucek P, Sund M, Talar-Wojnarowska R, Taylor PR, Theodoropoulos GE, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vodicka P, Wactawski-Wende J, Wentzensen N, Wu C, Yu H, Yu K, Zeleniuch-Jacquotte A, Hoover R, Hartge P, Fuchs C, Chanock SJ, Stolzenberg-Solomon RS, Amundadottir LT.

Nat Genet. 2014 Sep;46(9):994-1000. doi: 10.1038/ng.3052. Epub 2014 Aug 3.

23.

Who are you going to call? Primary care patients' disclosure decisions regarding direct-to-consumer genetic testing.

Wasson K, Cherny S, Sanders TN, Hogan NS, Helzlsouer KJ.

Narrat Inq Bioeth. 2014 Spring;4(1):53-68. doi: 10.1353/nib.2014.0026.

PMID:
24748260
24.

Arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum.

Aoki Y, Helzlsouer KJ, Strickland PT.

Int J Environ Res Public Health. 2014 Jan 27;11(2):1422-43. doi: 10.3390/ijerph110201422.

25.

Association between race and physical functioning limitations among breast cancer survivors.

Gallicchio L, Calhoun C, Helzlsouer KJ.

Support Care Cancer. 2014 Apr;22(4):1081-8. doi: 10.1007/s00520-013-2066-2. Epub 2013 Nov 29.

PMID:
24292017
26.

Aromatase inhibitor therapy and hair loss among breast cancer survivors.

Gallicchio L, Calhoun C, Helzlsouer KJ.

Breast Cancer Res Treat. 2013 Nov;142(2):435-43. doi: 10.1007/s10549-013-2744-2. Epub 2013 Nov 7.

PMID:
24197658
27.

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies.

Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, Brinton LA, Dorgan JF, Dossus L, Dowsett M, Eliassen AH, Fortner RT, Hankinson SE, Helzlsouer KJ, Hoff man-Bolton J, Comstock GW, Kaaks R, Kahle LL, Muti P, Overvad K, Peeters PH, Riboli E, Rinaldi S, Rollison DE, Stanczyk FZ, Trichopoulos D, Tworoger SS, Vineis P.

Lancet Oncol. 2013 Sep;14(10):1009-19. doi: 10.1016/S1470-2045(13)70301-2. Epub 2013 Jul 24.

28.

Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study.

Wasson K, Sanders TN, Hogan NS, Cherny S, Helzlsouer KJ.

J Community Genet. 2013 Oct;4(4):495-505. doi: 10.1007/s12687-013-0156-y. Epub 2013 Jul 7.

29.

Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer.

Gallicchio L, MacDonald R, Helzlsouer KJ.

J Cancer Res Clin Oncol. 2013 May;139(5):837-43. doi: 10.1007/s00432-013-1391-7. Epub 2013 Feb 14.

30.

Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.

Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, Hallmans G, Helzlsouer KJ, Hoffman-Bolton J, Hultén K, Sesso HD, Sowell AL, Tamimi RM, Toniolo P, Wilkens LR, Winkvist A, Zeleniuch-Jacquotte A, Zheng W, Hankinson SE.

J Natl Cancer Inst. 2012 Dec 19;104(24):1905-16. doi: 10.1093/jnci/djs461. Epub 2012 Dec 6.

31.

Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis.

Moore SC, Patel AV, Matthews CE, Berrington de Gonzalez A, Park Y, Katki HA, Linet MS, Weiderpass E, Visvanathan K, Helzlsouer KJ, Thun M, Gapstur SM, Hartge P, Lee IM.

PLoS Med. 2012;9(11):e1001335. doi: 10.1371/journal.pmed.1001335. Epub 2012 Nov 6.

32.

Shedding light on serum vitamin D concentrations and the risk of rarer cancers.

Helzlsouer KJ, Gallicchio L.

Anticancer Agents Med Chem. 2013 Jan;13(1):65-9.

PMID:
23094922
33.

DNA repair gene variants in relation to overall cancer risk: a population-based study.

Alberg AJ, Jorgensen TJ, Ruczinski I, Wheless L, Shugart YY, Berthier-Schaad Y, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Francis L, Alani RM, Smith MW, Strickland PT.

Carcinogenesis. 2013 Jan;34(1):86-92. doi: 10.1093/carcin/bgs304. Epub 2012 Oct 1.

34.

A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer.

Jorgensen TJ, Ruczinski I, Yao Shugart Y, Wheless L, Berthier Schaad Y, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Francis L, Alani RM, Strickland PT, Smith MW, Alberg AJ.

Cancer Epidemiol. 2012 Oct;36(5):e288-93. doi: 10.1016/j.canep.2012.05.001. Epub 2012 Jun 5.

35.

A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype.

Ruczinski I, Jorgensen TJ, Shugart YY, Schaad YB, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Wheless L, Francis L, Alani RM, Strickland PT, Smith MW, Alberg AJ.

Carcinogenesis. 2012 Sep;33(9):1692-8. doi: 10.1093/carcin/bgs170. Epub 2012 May 11.

36.

Fatigue in breast cancer survivors: the impact of a mind-body medicine intervention.

Appling SE, Scarvalone S, MacDonald R, McBeth M, Helzlsouer KJ.

Oncol Nurs Forum. 2012 May 1;39(3):278-86. doi: 10.1188/12.ONF.278-286.

PMID:
22543386
37.

Changes in bone biomarker concentrations and musculoskeletal symptoms among breast cancer patients initiating aromatase inhibitor therapy and women without a history of cancer.

Gallicchio L, MacDonald R, Wood B, Rushovich E, Fedarko NS, Helzlsouer KJ.

J Bone Miner Res. 2012 Sep;27(9):1959-66. doi: 10.1002/jbmr.1641.

38.

Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies.

Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, Jung S, Khudyakov P, Larsson SC, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Ross JA, Schouten LJ, Shikany JM, Tsugane S, Visvanathan K, Weiderpass E, Wolk A, Willett WC, Zhang SM, Ziegler RG, Smith-Warner SA.

Am J Clin Nutr. 2012 Mar;95(3):713-25. doi: 10.3945/ajcn.111.014415. Epub 2012 Jan 25.

39.

Daytime sleepiness and sleep duration in long-term cancer survivors and non-cancer controls: results from a registry-based survey study.

Forsythe LP, Helzlsouer KJ, MacDonald R, Gallicchio L.

Support Care Cancer. 2012 Oct;20(10):2425-32. doi: 10.1007/s00520-011-1358-7. Epub 2012 Jan 5.

PMID:
22218738
40.

Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy.

Gallicchio L, MacDonald R, Wood B, Rushovich E, Helzlsouer KJ.

Climacteric. 2012 Aug;15(4):339-49. doi: 10.3109/13697137.2011.620658. Epub 2011 Dec 23.

PMID:
22191462
41.

A prospective study of the associations between treated diabetes and cancer outcomes.

Yeh HC, Platz EA, Wang NY, Visvanathan K, Helzlsouer KJ, Brancati FL.

Diabetes Care. 2012 Jan;35(1):113-8. doi: 10.2337/dc11-0255. Epub 2011 Nov 18.

42.

A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms.

Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E.

Breast Cancer Res Treat. 2012 Jan;131(1):277-85. doi: 10.1007/s10549-011-1729-2. Epub 2011 Sep 9.

PMID:
21904883
43.

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies.

Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, Alberg AJ, Rollison DE, Dorgan JF, Brinton LA, Overvad K, Kaaks R, Trichopoulou A, Clavel-Chapelon F, Panico S, Duell EJ, Peeters PH, Rinaldi S, Fentiman IS, Dowsett M, Manjer J, Lenner P, Hallmans G, Baglietto L, English DR, Giles GG, Hopper JL, Severi G, Morris HA, Hankinson SE, Tworoger SS, Koenig K, Zeleniuch-Jacquotte A, Arslan AA, Toniolo P, Shore RE, Krogh V, Micheli A, Berrino F, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Lui LY, Cummings SR, Gunter MJ, Rohan TE, Strickler HD.

Br J Cancer. 2011 Aug 23;105(5):709-22. doi: 10.1038/bjc.2011.254. Epub 2011 Jul 19.

44.

The numbers game: the risky business of projecting risk.

Helzlsouer KJ.

J Natl Cancer Inst. 2011 Jul 6;103(13):992-3. doi: 10.1093/jnci/djr222. Epub 2011 Jun 24. No abstract available.

PMID:
21705680
45.

Managing the impact of posttreatment fatigue on the family: breast cancer survivors share their experiences.

Oktay JS, Bellin MH, Scarvalone S, Appling S, Helzlsouer KJ.

Fam Syst Health. 2011 Jun;29(2):127-37. doi: 10.1037/a0023947.

PMID:
21688904
46.

Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy.

Gallicchio L, Macdonald R, Wood B, Rushovich E, Helzlsouer KJ.

Breast Cancer Res Treat. 2011 Nov;130(2):569-77. doi: 10.1007/s10549-011-1611-2. Epub 2011 Jun 7.

PMID:
21647676
47.

Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.

Lai GY, Helzlsouer KJ, Clipp SL, Rifai N, Platz EA.

Cancer Prev Res (Phila). 2010 Oct;3(10):1334-41. doi: 10.1158/1940-6207.CAPR-10-0053. Epub 2010 Sep 21.

48.

Cruciferous vegetable intake and lung cancer risk: a nested case-control study matched on cigarette smoking.

Lam TK, Ruczinski I, Helzlsouer KJ, Shugart YY, Caulfield LE, Alberg AJ.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2534-40. doi: 10.1158/1055-9965.EPI-10-0475. Epub 2010 Sep 14.

49.

Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Helzlsouer KJ; VDPP Steering Committee.

Am J Epidemiol. 2010 Jul 1;172(1):4-9. doi: 10.1093/aje/kwq119. Epub 2010 Jun 18.

50.

Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Abnet CC, Chen Y, Chow WH, Gao YT, Helzlsouer KJ, Le Marchand L, McCullough ML, Shikany JM, Virtamo J, Weinstein SJ, Xiang YB, Yu K, Zheng W, Albanes D, Arslan AA, Campbell DS, Campbell PT, Hayes RB, Horst RL, Kolonel LN, Nomura AM, Purdue MP, Snyder K, Shu XO.

Am J Epidemiol. 2010 Jul 1;172(1):94-106. doi: 10.1093/aje/kwq121. Epub 2010 Jun 18.

Supplemental Content

Loading ...
Support Center